14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ALXO stock ended at $15.78. This is 2.73% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 6.70% from a day low at $15.38 to a day high of $16.41.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical ALX Oncology Holdings Inc. prices

Date Open High Low Close Volume
Jan 18, 2024 $14.04 $14.04 $12.69 $12.76 340 411
Jan 17, 2024 $13.80 $14.15 $13.29 $13.95 272 118
Jan 16, 2024 $14.11 $14.26 $13.66 $13.97 196 086
Jan 12, 2024 $14.05 $14.55 $14.05 $14.34 290 463
Jan 11, 2024 $14.32 $14.57 $13.79 $14.05 199 784
Jan 10, 2024 $14.43 $14.79 $14.16 $14.40 333 977
Jan 09, 2024 $14.15 $14.70 $13.97 $14.47 224 458
Jan 08, 2024 $12.51 $14.33 $12.45 $14.32 353 988
Jan 05, 2024 $13.06 $13.06 $12.51 $12.59 307 006
Jan 04, 2024 $13.59 $13.90 $13.05 $13.06 411 992
Jan 03, 2024 $14.14 $14.64 $13.82 $14.38 452 162
Jan 02, 2024 $14.71 $15.35 $14.31 $14.55 423 784
Dec 29, 2023 $15.04 $15.25 $14.66 $14.89 714 214
Dec 28, 2023 $14.79 $15.92 $14.78 $15.29 452 534
Dec 27, 2023 $15.17 $15.25 $14.68 $14.87 271 311
Dec 26, 2023 $15.44 $15.51 $14.93 $15.09 436 791
Dec 22, 2023 $13.40 $15.48 $13.40 $15.38 928 223
Dec 21, 2023 $13.60 $14.00 $12.94 $13.03 238 985
Dec 20, 2023 $13.92 $13.99 $13.14 $13.16 268 421
Dec 19, 2023 $13.67 $14.07 $13.67 $13.99 355 214
Dec 18, 2023 $13.36 $13.76 $13.07 $13.59 518 527
Dec 15, 2023 $13.39 $14.18 $13.36 $13.55 1 911 914
Dec 14, 2023 $13.68 $13.76 $12.81 $13.19 395 626
Dec 13, 2023 $12.93 $13.42 $12.67 $13.30 613 787
Dec 12, 2023 $12.98 $13.28 $12.28 $12.81 705 914
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT